↓ Skip to main content

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis

Overview of attention for article published in Arthritis Research & Therapy, June 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent
18 patents

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
102 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis
Published in
Arthritis Research & Therapy, June 2010
DOI 10.1186/ar3041
Pubmed ID
Authors

Fiona E McCann, Andrew C Palfreeman, Melanie Andrews, Dany P Perocheau, Julia J Inglis, Peter Schafer, Marc Feldmann, Richard O Williams, Fionula M Brennan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
United Kingdom 1 <1%
Denmark 1 <1%
Unknown 97 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 25%
Other 14 14%
Researcher 14 14%
Student > Master 10 10%
Student > Bachelor 7 7%
Other 18 18%
Unknown 13 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 23 23%
Medicine and Dentistry 22 22%
Biochemistry, Genetics and Molecular Biology 9 9%
Immunology and Microbiology 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Other 17 17%
Unknown 18 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2019.
All research outputs
#3,798,611
of 25,373,627 outputs
Outputs from Arthritis Research & Therapy
#902
of 3,381 outputs
Outputs of similar age
#14,618
of 105,269 outputs
Outputs of similar age from Arthritis Research & Therapy
#12
of 39 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,269 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.